Home › Myasthenia Gravis › Massachusetts
Myasthenia Gravis clinical trials in Massachusetts
11 studies for Myasthenia Gravis are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Neurology Center Of New England PC, Foxborough
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT07217587ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Massachusetts General Hospital, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07284420AXIS MG Patient Registry
- Alira Health - Virtual/Remote Site - Can Be Completed 100% Online - All US Residents Accepted, Framingham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07761026RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Beth Israel Deaconess Medical Center, Boston
- University of Massachusetts Chan Medical School, Worcester
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Aug 13, 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1049, Foxborough
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Neurology Center of New England, Foxborough
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06456580Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Research Site, Boston
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT06312644Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565Myasthenia Gravis Foundation of America Global MG Patient Registry
- Myasthenia Gravis Foundation of America, Westborough
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 27, 2024 · NCT06617741From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.